{
  "name": "biomarker",
  "description": "The collection of data elements describing a donor's biomarker tests. A biomarker is a biological molecule found in blood, other body fluids, or tissues that is indicative of the presence of cancer in the body. Each row should include biomarker tests associated with a particular clinical event or time interval.",
  "meta": {
    "parent": "donor"
  },
  "fields": [
    {
      "name": "program_id",
      "valueType": "string",
      "description": "Unique identifier of the ARGO program.",
      "meta": {
        "validationDependency": true,
        "primaryId": true,
        "foreignKey": "sample_registration.program_id",
        "displayName": "Program ID"
      },
      "restrictions": {
        "required": true
      }
    },
    {
      "description": "Unique identifier of the donor, assigned by the data provider.",
      "name": "submitter_donor_id",
      "valueType": "string",
      "meta": {
        "validationDependency": true,
        "primaryId": true,
        "foreignKey": "sample_registration.submitter_donor_id",
        "displayName": "Submitter Donor ID"
      },
      "restrictions": {
        "required": true,
        "regex": "#/regex/submitter_id"
      }
    },
    {
      "name": "submitter_specimen_id",
      "description": "Unique identifier of the specimen, assigned by the data provider.",
      "valueType": "string",
      "meta": {
        "validationDependency": true,
        "primaryId": true,
        "foreignKey": "sample_registration.submitter_specimen_id",
        "displayName": "Submitter Specimen ID"
      },
      "restrictions": {
        "regex": "#/regex/submitter_id"
      }
    },
    {
      "name": "submitter_primary_diagnosis_id",
      "valueType": "string",
      "description": "If the biomarker test was done at the time of primary diagnosis, then indicate the associated submitter_primary_diagnosis_id here.",
      "meta": {
        "displayName": "Submitter Primary Diagnosis ID",
        "primaryId": true
      },
      "restrictions": {
        "regex": "#/regex/submitter_id"
      }
    },
    {
      "name": "submitter_treatment_id",
      "valueType": "string",
      "description": "If the biomarker test was done at the initiation of a specific treatment regimen, indicate the associated submitter_treatment_id here.",
      "meta": {
        "primaryId": true,
        "displayName": "Submitter Treatment ID"
      },
      "restrictions": {
        "regex": "#/regex/submitter_id"
      }
    },
    {
      "description": "If the biomarker test was done during a follow-up event, then indicate the associated submitter_follow_up_id here.",
      "name": "submitter_follow_up_id",
      "valueType": "string",
      "meta": {
        "validationDependency": true,
        "primaryId": true,
        "displayName": "Submitter Follow-Up ID"
      },
      "restrictions": {
        "regex": "#/regex/submitter_id"
      }
    },
    {
      "description": "If the biomarker test was not associated with a specific follow-up, primary diagnosis or treatment event, then indicate the interval of time since primary diagnosis that the biomarker test was performced at, in days.",
      "name": "test_interval",
      "valueType": "integer",
      "restrictions": {
        "range": {
           "exclusiveMin": 0
        }
      },
      "meta": {
        "validationDependency": true,
        "primaryId": true,
        "units": "days",
        "displayName": "Interval Of Test",
        "notes": "This field is required if the biomarker test is not associated with a primary diagnosis, treatment or follow-up event. The associated primary diagnosis is used as the reference point for this interval. To calculate this, find the number of days since the date of primary diagnosis."
      }
    },
    {
      "description": "Indicate the level of carbohydrate antigen 19-9 (CA19-9). Carbohydrate antigen 19-9 testing is useful to monitor the response to treatment in pancreatic cancer patients. (Reference: LOINC: 24108-3)",
      "name": "ca19-9_level",
      "valueType": "integer",
      "restrictions": {
        "range": {
           "exclusiveMin": 0
        }
      },
      "meta": {
        "displayName": "CA19-9 Level"
      }
    },
    {
      "description": "Indicate the quantitative measurement of the amount of C-reactive protein (CRP), an inflammatory marker, in the blood in mg/L. (Reference: NCIt C64548)",
      "name": "crp_levels",
      "valueType": "integer",
      "restrictions": {
        "range": {
           "exclusiveMin": 0
        }
      },
      "meta": {
        "displayName": "C-reactive protein (CRP) Level"
      }
    },
    {
      "description": "Indicate the level of lactate dehydrogenase (LDH), in IU/L.",
      "name": "ldl_level",
      "valueType": "integer",
      "restrictions": {
        "range": {
           "exclusiveMin": 0
        }
      },
      "meta": {
        "displayName": "Lactate Dehydrogenase (LDH) Level"
      }
    },
    {
      "description": "Indicate the value for a hemotology laboratory test for the absolute number of neutrophil cells (ANC) present in a sample of peripheral blood from a donor, in cells/uL. (Reference: caDSR CDE ID 2180198)",
      "name": "anc",
      "valueType": "integer",
      "restrictions": {
        "range": {
           "exclusiveMin": 0
        }
      },
      "meta": {
        "displayName": "Absolute Neutrophil Count (ANC)"
      }
    },
    {
      "description": "Indicate the absolute number of lymphocytes (ALC) found in a given volume of blood, as cells/uL. (Reference: NCIt: C113237)",
      "name": "alc",
      "valueType": "integer",
      "restrictions": {
        "range": {
           "exclusiveMin": 0
        }
      },
      "meta": {
        "displayName": "Absolute Lymphocyte Count (ALC)"
      }
    },
    {
      "description": "Indicate whether donor is a carrier of a mutation in a BRCA gene.",
      "name": "brca_carrier",
      "valueType": "string",
      "restrictions": {
        "codeList": [
           "BRCA1",
           "BRCA2",
           "Both BRCA1 and BRCA2",
           "No",
           "Not applicable",
           "Unknown"
        ]
      },
      "meta": {
        "displayName": "BRCA Carrier"
      }
    },
    {
      "description": "Indicate the expression of estrogen receptor (ER). (Reference: NAACCR 3827)",
      "name": "er_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "Estrogen Receptor Status"
      }
    },
    {
      "description": "Indicate the Allred score. The Allred score is based on the percentage of cells that stain positive by immunohistochemistry (IHC) for estrogen receptor (ER) and the intensity of that staining. (Reference: NAACCR: 3828, caDSR CDE ID 2725288)",
      "name": "er_allred_score",
      "valueType": "string",
      "restrictions": {
        "codeList": [
           "Total ER Allred score of 1",
           "Total ER Allred score of 2",
           "Total ER Allred score of 3",
           "Total ER Allred score of 4",
           "Total ER Allred score of 5",
           "Total ER Allred score of 6",
           "Total ER Allred score of 7",
           "Total ER Allred score of 8",
           "Not applicable",
           "Unknown"
        ]
      },
      "meta": {
        "displayName": "Estrogen Receptor Allred Score"
      }
    },
    {
      "name": "er_percent_positive",
      "description": "Indicate a value, in decimals, that represents the percent of cells staining estrogen receptor positive by IHC.",
      "valueType": "number",
      "meta": {
        "displayName": "Estrogen Receptor Percent Positive"
      },
      "restrictions": {
         "range": {
            "min": 0,
            "max": 1
          }
      }
    },
    {
      "description": "Indicate the expression of human epidermal growth factor receptor-2 (HER2) assessed by immunohistochemistry (IHC). (Reference: AJCC 8th Edition, Chapter 48)",
      "name": "her2_ihc_status",
      "valueType": "string",
      "restrictions": {
        "codeList": [
           "Cannot be determined",
           "Equivocal",
           "Negative",
           "Not applicable",
           "Positive",
           "Unknown"
        ]
      },
      "meta": {
        "displayName": "HER2 IHC Status",
        "notes": "Negative: 0 or 1+ staining, Equivocal: 2+ staining, Positive: 3+ staining"
      }
    },
    {
      "description": "Indicate the expression of human epidermal growth factor receptor-2 (HER2) assessed by in situ hybridization (ISH). (Reference: NAACCR: 3854)",
      "name": "her2_ish_status",
      "valueType": "string",
      "restrictions": {
        "codeList": [
           "Cannot be determined",
           "Equivocal",
           "Positive",
           "Negative",
           "Not applicable",
           "Unknown"
        ]
      },
      "meta": {
        "displayName": "HER2 ISH Status"
      }
    },
    {
      "description": "Indicate the expression of progestrone receptor (PR). (Reference: NAACCR 3915)",
      "name": "pr_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "Progesterone Receptor Status"
      }
    },
    {
      "description": "Indicate the Allred score. The Allred score is based on the percentage of cells that stain positive by IHC for the progesterone receptor (PR) and the intensity of that staining. (Reference: NAACCR: 3916)",
      "name": "pr_allred_score",
      "valueType": "string",
      "restrictions": {
        "codeList": [
           "Total PR Allred score of 1",
           "Total PR Allred score of 2",
           "Total PR Allred score of 3",
           "Total PR Allred score of 4",
           "Total PR Allred score of 5",
           "Total PR Allred score of 6",
           "Total PR Allred score of 7",
           "Total PR Allred score of 8",
           "Not applicable",
           "Unknown"
        ]
      },
      "meta": {
        "displayName": "Progesterone Receptor Allred Score"
      }
    },
    {
      "name": "pr_percent_positive",
      "description": "Indicate a value, in decimals, that represents the percent of cells staining progesterone receptor positive by IHC.",
      "valueType": "number",
      "meta": {
        "displayName": "Progesterone Receptor Percent Positive"
      },
      "restrictions": {
         "range": {
            "min": 0,
            "max": 1
          }
      }
    },
    {
      "description": "Indicate the immunohistochemical test result that refers to the overexpression or lack of expression of programmed death ligand 1 (PD-L1) in a tissue sample of a primary or metastatic malignant neoplasm. (Reference NCIt: C122807)",
      "name": "pd-l1_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "PD-L1 Status"
      }
    },
    {
      "description": "Indicate the expression of anaplastic lymphoma receptor tyrosine kinase (ALK) as assessed by immunohistochemistry (IHC).",
      "name": "alk_ihc_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "ALK IHC Status"
      }
    },
    {
      "description": "Indicate the intensity of anaplastic lymphoma receptor tyrosine kinase (ALK) as assessed by immunohistochemistry (IHC).",
      "name": "alk_ihc_intensity",
      "valueType": "string",
      "restrictions": {
        "codeList": [
           "0 (No stain)",
           "+1",
           "+2",
           "+3"
        ]
      },
      "meta": {
        "displayName": "ALK IHC Intensity"
      }
    },
    {
      "description": "Indicate the expression of anaplastic lymphoma receptor tyrosine kinase (ALK) as assessed by flurescence in situ hybridization (FISH).",
      "name": "alk_fish_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "ALK FISH Status"
      }
    },
    {
      "description": "Indicate the expression of receptor lymphoma kinase (ROS1) as assessed by immunohistochemistry (IHC).",
      "name": "ros1_ihc_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "ROS1 IHC Status"
      }
    },
    {
      "description": "Indicate the expression of Pan-TRK as assessed by immunohistochemistry (IHC).",
      "name": "pan-trk_ihc_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "Pan-TRK IHC Status"
      }
    },
    {
      "description": "Indicate the expression of gene arrangement involving the RET proto-oncogene (RET1) as assessed by fluoresence in situ hybridization (FISH). RET gene rearrangements are associated with several different neoplastic conditions. (Reference: NCIt C46005)",
      "name": "ret_fish_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "RET1 FISH Status"
      }
    },
    {
      "description": "Indicate the expression of tropomyosin receptor kinase (TRK) as assessed by immunohistochemistry (IHC).",
      "name": "trk_ihc_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "TRK IHC Status"
      }
    },
    {
      "description": "Indicate the expression of Human papillomavirus (HPV) p16 as assessed by immunohistochemistry (IHC).",
      "name": "hpv_ihc_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "HPV IHC Status"
      }
    },
    {
      "description": "Indicate the expression of Human papillomavirus (HPV) as assessed using a laboratory test in which cells are scraped from the cervix to look for DNA of HPV. (Reference: NCIt C93141)",
      "name": "hpv_dna_status",
      "valueType": "string",
      "restrictions": {
        "codeList": "#/list/expression_status"
      },
      "meta": {
        "displayName": "HPV DNA Status"
      }
    }
  ]
}
